Christopher Astle Insider Profile

4 Followers
Christopher Astle, Senior Vice-President & Chief Financial Officer at Zymeworks, holds 6.50K shares in Zymeworks (Ticker: ZYME). Most recently, Christopher Astle Sold $5,994 shares of Zymeworks on Jan 08, 2024 for an estimated value of 64.66K.
tipranks
Christopher  Astle

Christopher Astle
Zymeworks (ZYME)
Senior Vice-President & Chief Financial Officer

Not Ranked
Christopher Astle has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$109K
100.00%
A breakdown of Christopher Astle's holdings

Insider Roles

Zymeworks
(ZYME)
Senior Vice-President & Chief Financial Officer
Roles that Christopher Astle holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Christopher Astle

Christopher Astle's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Zymeworks
Jan 08, 2024
Senior Vice-President & Chief Financial Officer
Informative Sell
64.66K
$109.06K
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jan 08, 2024
Informative Sell
$64.66K
-
$10.79
List of latest transactions for each holding click on a transaction to see Christopher Astle's performance on stock

Christopher Astle insider profile FAQ

What is the percentage of profitable transactions made by Christopher Astle?
The percentage of profitable transactions made by Christopher Astle is ―.
    What is the average return per transaction made by Christopher Astle?
    The average return per transaction made by Christopher Astle is ―.
      What stocks does Christopher Astle hold?
      Christopher Astle holds: ZYME stocks.
        What was Christopher Astle’s latest transaction?
        Christopher Astle latest transaction was an Informative Sell of $64.66K.
          What was Christopher Astle's most profitable transaction?
          Christopher Astle’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Christopher Astle's role in Zymeworks?
            Christopher Astle's role in Zymeworks is Senior Vice-President & Chief Financial Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.